Licencing Deal Signed

Professor Simon Cutting of SporeGen® signed an agreement with Mr Phan Chien Thang C.E.O. of NG Biotech (Hanoi, Vietnam). The agreement will cover the exploitation of novel Bacillus strains for use as

Read More

SporeGen® Awarded EMI-TB Grant

SporeGen® has been made a partner on the Horizon 2020 EMI-TB Grant focusing on developing innovative mucosal vaccines to TB, utilising the SporeGen® “SporeVax” technology. The grant is led by

Read More


  • February 12, 2015
  • SporeGen

SporeGen®is proud to be working with PATH and Dr. R. Aroian (University of Massachusetts) on a project that could ultimately lead to a significant impact on soil-transmitted helminth infections

Read More
1 2 3 4 5